Outpatient 60-hour day-and-night glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or sensor-augmented pump therapy in adults with type 1 diabetes: An open-label, randomised, crossover, controlled trial-Reference-Cited by-同舟云学术

Outpatient 60-hour day-and-night glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or sensor-augmented pump therapy in adults with type 1 diabetes: An open-label, randomised, crossover, controlled trial

Published:2017-03-08 Issue:5 Volume:19 Page:713-720
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Haidar Ahmad¹²^ORCID,Messier Virginie³,Legault Laurent⁴,Ladouceur Martin⁵⁶,Rabasa-Lhoret Rémi³⁵⁷⁸

Affiliation:

1. Faculty of Medicine, Department of Biomedical Engineering; McGill University; Montréal Québec Canada

2. Faculty of Medicine, Division of Endocrinology and Metabolism; McGill University; Montréal Québec Canada

3. Institut de recherches cliniques de Montréal; Montréal Québec Canada

4. Montreal Children's Hospital; McGill University Health Centre; Montréal Québec Canada

5. The Research Center of the Université de Montréal Hospital Center; Montréal Québec Canada

6. Département de Médecine Sociale et Préventive, School of Public Health; Université de Montréal; Montréal Québec Canada

7. Faculty of Medicine, Nutrition Department; Université de Montréal; Montréal Québec Canada

8. Montreal Diabetes Research Center; Montréal Québec Canada

Funder

Canadian Institutes of Health Research

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12880/fullpdf

Reference23 articles.

1. Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D exchange clinic registry;Miller;Diabetes Care,2015

2. Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes;Cryer;Diabetologia,2002

3. Frequency of biochemical hypoglycaemia in adults with Type 1 diabetes with and without impaired awareness of hypoglycaemia: no identifiable differences using continuous glucose monitoring;Choudhary;Diabet Med,2010

4. Severe hypoglycemia requiring medical intervention in a large cohort of adults with diabetes receiving care in U.S. integrated health care delivery systems: 2005-2011;Pathak;Diabetes Care,2016

5. Acute complications and drug misuse are important causes of death for children and young adults with type 1 diabetes: results from the Yorkshire Register of diabetes in children and young adults;Feltbower;Diabetes Care,2008

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Themes, Rates, and Risk of Adverse Events of the Artificial Pancreas in the United States Using MAUDE;Annals of Biomedical Engineering;2024-05-13

2. Controlling Human Physiology via Drugs and Devices;Reference Module in Materials Science and Materials Engineering;2024

3. A Randomized Crossover Trial to Compare Automated Insulin Delivery (the Artificial Pancreas) With Carbohydrate Counting or Simplified Qualitative Meal-Size Estimation in Type 1 Diabetes;Diabetes Care;2023-05-03

4. Translational aspects of glucagon: current use and future prospects;Journal of Endocrinology;2023-02-02

5. Closed-Loop Artificial Pancreas Therapy for Type 1 Diabetes;Current Cardiology Reports;2022-06-21